文献速递心律失常血脂与心血管预防

英格兰房颤相关卒中住院10年趋势与口服抗凝使用关联

A 10 year study of hospitalized atrial fibrillation-related stroke in England and its association with uptake of oral anticoagulation.
PubMed 文献 · Eur Heart J · 2018-01-01

该研究基于2006–2016年英格兰国家数据库,分析房颤相关卒中住院率与口服抗凝药使用的关系。房颤患病率从1.29%升至1.71%,CHA2DS2-VASc≥2患者抗凝使用从48.0%升至78.6%。2011年后房颤相关卒中住院率下降,校正房颤患病率后抗凝使用每增1%与每周卒中率降0.8%相关。

要点

  • 房颤患病率与抗凝使用同步上升,抗凝增加与卒中住院率下降显著相关。
  • CHA2DS2-VASc≥2患者抗凝比例从48.0%升至78.6%,抗血小板使用下降。
  • 若抗凝使用维持2009年水平,2015/2016年预计多发生4068例卒中。

核心结论

  • 2006–2016年英格兰房颤患病率和抗凝使用增加,2011年后房颤相关卒中住院率下降且与抗凝使用增加显著相关。

研究设计与样本

  • 基于英格兰国家数据库2006–2016年的回顾性分析,评估房颤相关卒中住院与口服抗凝使用。

主要发现

  • 已知房颤患者从692 054增至983 254,患病率从1.29%升至1.71%。
  • 每10万房颤患者中房颤相关卒中住院从2006年80/周增至2011年98/周,2016年降至86/周(2006–2011差值18.0,95%CI 17.9–18.1;2011–2016差值-12.0,95%CI -12.1至-11.9)。
  • CHA2DS2-VASc≥2患者抗凝使用从48.0%升至78.6%,抗血小板使用从42.9%降至16.1%;抗凝增幅在第二个5年更大(2006–2011差值4.8%,95%CI 4.5–5.1%;2011–2016差值25.8%,95%CI 25.5–26.1%)。
  • 校正房颤患病率后,抗凝使用每增1%与每周房颤相关卒中率降0.8%相关(发生率比0.992,95%CI 0.989–0.994)。
  • 若抗凝使用维持2009年水平,2015/2016年预计多发生4068例卒中(95%CI 4046–4089)。

临床怎么用

  • 在房颤卒中预防中,提高CHA2DS2-VASc≥2患者的抗凝使用可能有助于降低房颤相关卒中住院率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To determine whether changing patterns of anticoagulant use in atrial fibrillation (AF) have impacted on stroke rates in England. METHODS AND RESULTS: English national databases, 2006-2016, were interrogated to assess stroke admissions and oral anticoagulant use. The number of patients with known AF increased linearly from 692 054 to 983 254 (prevalence 1.29% vs. 1.71%). Hospital episodes of AF-related stroke/100 000 AF patients increased from 80/week in 2006 to 98/week in 2011 and declined to 86/week in 2016 (2006-2011 difference 18.0, 95% confidence interval (CI) 17.9-18.1, 2011-2016 difference -12.0, 95% CI -12.1 to -11.9). Anticoagulant use amongst patients with CHA2DS2-VASc ≥2 increased from 48.0% to 78.6% and anti-platelet use declined from 42.9% to 16.1%; the greatest rate of change occurred in the second 5 year period (for anticoagulants 2006-2011 difference 4.8%, 95% CI 4.5-5.1%, 2011-2016 difference 25.8%, 95% CI 25.5-26.1%). After adjustment for AF prevalence, a 1% increase in anticoagulant use was associated with a 0.8% decrease in the weekly rate of AF-related stroke (incidence rate ratio 0.992, 95% CI 0.989-0.994). Had the use of anticoagulants remained at 2009 levels, 4068 (95% CI 4046-4089) more strokes would have been predicted in 2015/2016. CONCLUSION: Between 2006 and 2016, AF prevalence and anticoagulant use in England increased. From 2011, hospitalized AF-related stroke rates declined and were significantly associated with increased anticoagulant uptake.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Cowan JC, Wu J, Hall M, et al. A 10 year study of hospitalized atrial fibrillation-related stroke in England and its association with uptake of oral anticoagulation. Eur Heart J. 2018. PMID: 29982405. doi:10.1093/eurheartj/ehy411

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。